Cor Vasa 2025, 67(4):457-463 | DOI: 10.33678/cor.2025.071
(Mitral regurgitation - a review article)
- a II. interní klinika kardiologie a angiologie, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice v Praze, Praha
Mitral regurgitation (MR) represents one of the most prevalent valvular heart pathologies, with its pathophysiological mechanism closely associated with structural and morphological alterations of the mitral valve (MV), which may be of congenital or acquired origin. Accurate and systematic echocardiographic evaluation of both anatomical and functional components of the MV is essential for the optimal timing of therapeutic interventions, whether surgical, transcatheter, or conservative, with the aim of improving clinical outcomes and long-term prognosis. A comprehensive assessment of MV anatomy, including leaflet morphology, annular geometry, subvalvular apparatus, and papillary muscle configuration, is critical for understanding the pathomechanics of regurgitation and its progression. These structures exhibit variability influenced by age, ventricular remodeling, and underlying comorbidities, necessitating an individualized diagnostic approach. Contemporary practice highlights the central role of advanced echocardiographic modalities, particularly three-dimensional transthoracic and transesophageal echocardiography, in the precise characterization of MV pathology. This imaging strategy supports accurate quantification of regurgitant severity and facilitates procedural planning. A patient-tailored approach remains essential for selecting the most appropriate therapeutic strategy and optimizing clinical management.
Keywords: Barlow's disease, Fibroelastic degeneration, Mitral regurgitation, Mitral valve echocardiography, Mitral valve repair echocardiography,
Received: June 1, 2025; Revised: June 11, 2025; Accepted: June 14, 2025; Prepublished online: June 2, 2012; Published: October 6, 2025 Show citation
References
- Kopuz C, Erk K, Sancar Baris Y, et al. Morphometry of the fibrous ring of the mitral valve. Ann Anat 1995;177:151-154.
Go to original source...
Go to PubMed...
- Lancellotti P, Moura L, Pierard LA, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010;11:307-332.
Go to original source...
Go to PubMed...
- Dal-Bianco JP, Beaudoin J, Handschumacher MD, Levine RA. Basic mechanisms of mitral regurgitation. Can J Cardiol 2014;30:971-981.
Go to original source...
Go to PubMed...
- El Sabbagh A, Reddy YNV, Nishimura RA. Mitral Valve Regurgitation in the Contemporary Era. JACC Cardiovasc Imaging 2018;11:628-643.
Go to original source...
Go to PubMed...
- Gasser S, Reichenspurner H, Girdauskas E. Genomic analysis in patients with myxomatous mitral valve prolapse: current state of knowledge. BMC Cardiovasc Disord 2018;18:41.
Go to original source...
Go to PubMed...
- Anyanwu AC, Adams DH. Etiologic Classification of Degenerative Mitral Valve Disease: Barlow's Disease and Fibroelastic Deficiency. Semin Thorac Cardiovasc Surg 2007;19:90-96.
Go to original source...
Go to PubMed...
- Hjortnaes J, Keegan J, Bruneval P, et al. Comparative Histopathological Analysis of Mitral Valves in Barlow Disease and Fibroelastic Deficiency. Semin Thorac Cardiovasc Surg 2016;28:757-767.
Go to original source...
- Vergara P, Altizio S, Falasconi G, et al. Electrophysiological Substrate in Patients with Barlow's Disease. Arrhythm Electrophysiol Rev 2021;10:33-37.
Go to original source...
- Fishbein GA, Fishbein MC. Mitral Valve Pathology. Curr Cardiol Rep 2019;21:61.
Go to original source...
- Lancellotti P, Tribouilloy C, Hagendorff A, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2013;14:611-644.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.